These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12431683)

  • 41. Bibliography. Current world literature. Vasculitis syndromes.
    Curr Opin Rheumatol; 1999 Jan; 11(1):B1-13. PubMed ID: 9894637
    [No Abstract]   [Full Text] [Related]  

  • 42. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
    de Groot K; Harper L; Jayne DR; Flores Suarez LF; Gregorini G; Gross WL; Luqmani R; Pusey CD; Rasmussen N; Sinico RA; Tesar V; Vanhille P; Westman K; Savage CO;
    Ann Intern Med; 2009 May; 150(10):670-80. PubMed ID: 19451574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic small vessel vasculitis: pathophysiological aspects of antineutrophil cytoplasm antibodies (ANCA). A review on recent findings.
    Wiik A
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S51-3. PubMed ID: 15309795
    [No Abstract]   [Full Text] [Related]  

  • 44. Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis.
    Weidner S; Hafezi-Rachti S; Rupprecht HD
    Arthritis Rheum; 2006 Feb; 55(1):146-9. PubMed ID: 16463427
    [No Abstract]   [Full Text] [Related]  

  • 45. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
    Feldmann M; Pusey CD
    J Am Soc Nephrol; 2006 May; 17(5):1243-52. PubMed ID: 16624928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia.
    Hamidou MA; El Kouri D; Audrain M; Grolleau JY
    Ann Rheum Dis; 2001 Mar; 60(3):293-5. PubMed ID: 11171697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 4. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside.
    Yoshida M
    Intern Med; 2002 Jan; 41(1):47-9. PubMed ID: 11838592
    [No Abstract]   [Full Text] [Related]  

  • 48. The evolving pathogenesis of systemic vasculitis.
    Savage CO
    Clin Med (Lond); 2002; 2(5):458-64. PubMed ID: 12448596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascade.
    Hayes MJ; Cambridge G
    Mol Immunol; 2004 Jun; 41(4):457-68. PubMed ID: 15163542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrence of ANCA-associated vasculitis in a patient with kidney trasplant.
    García Cosmes P; Fraile Gómez P; Lewczuk K; Rodríguez González M; Ruiz Ferreras E; Tabernero Fernández G
    Nefrologia; 2016; 36(2):176-80. PubMed ID: 26850517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of ANCA-positive vasculitis with thyroid disease.
    Rothe HM; Siegmund J; Müller H; Wopperer J
    Nephrol Dial Transplant; 2008 Jun; 23(6):2107; author reply 2107-8. PubMed ID: 18323519
    [No Abstract]   [Full Text] [Related]  

  • 52. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation.
    Elmedhem A; Adu D; Savage CO
    Nephrol Dial Transplant; 2003 May; 18(5):1001-4. PubMed ID: 12686678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known.
    de Lind van Wijngaarden RA; van Rijn L; Hagen EC; Watts RA; Gregorini G; Tervaert JW; Mahr AD; Niles JL; de Heer E; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):237-52. PubMed ID: 18077783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrence of ANCA-associated microscopic polyangiitis after cadaveric renal transplant.
    Le Mao G; Rostaing L; Modesto A; Oksman F; Cisterne JM; Durand D
    Transplant Proc; 1996 Oct; 28(5):2803-4. PubMed ID: 8908067
    [No Abstract]   [Full Text] [Related]  

  • 55. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
    Levine SM
    Ann Intern Med; 2010 Jan; 152(1):65; author reply 65. PubMed ID: 20048281
    [No Abstract]   [Full Text] [Related]  

  • 56. [Diffuse pulmonary hemorrhage associated with antineutrophil cytoplasmic antibodies. Findings of high-resolution computerized tomography. A case report].
    Galeotti R; Sala S; Rosina G; Mannella P
    Radiol Med; 1997 Dec; 94(6):685-7. PubMed ID: 9524614
    [No Abstract]   [Full Text] [Related]  

  • 57. Anti-thymocyte globulin therapy in a patient with pANCA vasculitis and crescentic glomerulonephritis.
    Lukas R; Keller F
    Nephron; 1998; 78(2):231. PubMed ID: 9496748
    [No Abstract]   [Full Text] [Related]  

  • 58. Various forms of life in antineutrophil cytoplasmic antibody-associated vasculitis.
    Hogan SL; Falk RJ; Nachman PH; Jennette JC
    Ann Intern Med; 2006 Mar; 144(5):377-8; author reply 378-9. PubMed ID: 16520483
    [No Abstract]   [Full Text] [Related]  

  • 59. Translational research in autoimmunity: aims of therapy in vasculitis.
    Watts R; Harper L; Jayne D; Levy J; Pusey C; Savage C; Scott DG; Williams J
    Rheumatology (Oxford); 2005 May; 44(5):573-6. PubMed ID: 15797978
    [No Abstract]   [Full Text] [Related]  

  • 60. Anti-endothelial cell antibodies in patients with AAV: the relationship with ANCA? Comment on: Identification of target antigens of anti-endothelial cell antibodies in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides: a proteomic approach.
    Gou SJ; Fu P
    Clin Immunol; 2014 Oct; 154(2):188. PubMed ID: 25108051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.